Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise

E-ISSN： 1873-4286|14|21|2051-2060

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.21, 2008-07, pp. : 2051-2060

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting RSK2 in human malignancies

By Kang Sumin Chen Jing

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 1, 2011-01 ,pp. : 11-20

Informa Healthcare

Access to resources Recommend Favorite

Nutritional Targeting of Cyclooxygenase-2 for Colon Cancer Prevention

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 9, Iss. 3, 2010-07 ,pp. : 181-191

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclo-Oxygenase-2 Inhibitors: Rationale and Therapeutic Potential for Alzheimers Disease

By McGeer P.L.

Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

ENMD-2076 for hematological malignancies

By How Jonathan Yee Karen

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 5, 2012-05 ,pp. : 717-732

Informa Healthcare

Access to resources Recommend Favorite

Novel Immunotherapies for Hematological Malignancies

Current Molecular Pharmacology, Vol. 9, Iss. 3, 2016-09 ,pp. : 264-271

Bentham Science Publishers

Access to resources Recommend Favorite